{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T02:07:50Z","timestamp":1788746870260,"version":"build-2803163510"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"vor","delay-in-days":75,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81760383, 82160106"],"award-info":[{"award-number":["81760383, 82160106"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81760383, 82160106"],"award-info":[{"award-number":["81760383, 82160106"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81760383, 82160106"],"award-info":[{"award-number":["81760383, 82160106"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"International Cooperative Research Program of the Second Affiliated Hospital of Kunming Medical University","award":["2022dwhz01, 2022dwhz13"],"award-info":[{"award-number":["2022dwhz01, 2022dwhz13"]}]},{"name":"International Cooperative Research Program of the Second Affiliated Hospital of Kunming Medical University","award":["2022dwhz01, 2022dwhz13"],"award-info":[{"award-number":["2022dwhz01, 2022dwhz13"]}]},{"name":"Yunnan Provincial Department of Education Scientific Research Fund Project","award":["2025J0270"],"award-info":[{"award-number":["2025J0270"]}]},{"name":"Yunnan Provincial Science and Technology Plan Project, Kunming Medical University Joint Special Project","award":["202501AY070001-086"],"award-info":[{"award-number":["202501AY070001-086"]}]},{"name":"Yunnan Provincial Science and Technology Plan Project, Kunming Medical University Joint Special Project","award":["202401AY070001-077"],"award-info":[{"award-number":["202401AY070001-077"]}]},{"name":"\"Talent Echelon Construction\" training project of the Second Affiliated Hospital of Kunming Medical University","award":["RCTDXK-202301,RCTDHB-202317"],"award-info":[{"award-number":["RCTDXK-202301,RCTDHB-202317"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-026-05040-9","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T03:18:22Z","timestamp":1782271102000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic nutritional index as a predictor of ursodeoxycholic acid response in primary biliary cholangitis: a retrospective study"],"prefix":"10.1186","volume":"26","author":[{"given":"Mengyao","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongtao","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyu","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiling","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiying","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenlin","family":"Tai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,24]]},"reference":[{"issue":"1","key":"5040_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12072-021-10276-6","volume":"16","author":"H You","year":"2022","unstructured":"You H, Ma X, Efe C, Wang G, Jeong SH, Abe K, et al. APASL clinical practice guidance: the diagnosis and management of patients with primary biliary cholangitis. Hepatol Int. 2022;16(1):1\u201323.","journal-title":"Hepatol Int"},{"issue":"1","key":"5040_CR2","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.cld.2023.07.002","volume":"28","author":"SK Shah","year":"2024","unstructured":"Shah SK, Bowlus CL. Autoimmune Markers in Primary Biliary Cholangitis. Clin Liver Dis. 2024;28(1):93\u2013101.","journal-title":"Clin Liver Dis"},{"issue":"6","key":"5040_CR3","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1111\/jgh.15329","volume":"36","author":"T Lv","year":"2021","unstructured":"Lv T, Chen S, Li M, Zhang D, Kong Y, Jia J. Regional variation and temporal trend of primary biliary cholangitis epidemiology: A systematic review and meta-analysis. J Gastroenterol Hepatol. 2021;36(6):1423\u201334.","journal-title":"J Gastroenterol Hepatol"},{"issue":"3","key":"5040_CR4","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1002\/hep.22428","volume":"48","author":"C Corpechot","year":"2008","unstructured":"Corpechot C, Abenavoli L, Rabahi N, Chr\u00e9tien Y, Andr\u00e9ani T, Johanet C, et al. Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis. Hepatology. 2008;48(3):871\u20137.","journal-title":"Hepatology"},{"issue":"3","key":"5040_CR5","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.cgh.2019.08.013","volume":"18","author":"NK Gatselis","year":"2020","unstructured":"Gatselis NK, Goet JC, Zachou K, Lammers WJ, Janssen HLA, Hirschfield G, et al. Factors Associated With Progression and Outcomes of Early Stage Primary Biliary Cholangitis. Clin Gastroenterol Hepatol. 2020;18(3):684\u2013e926.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"11\u201312","key":"5040_CR6","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1080\/17474124.2022.2153672","volume":"16","author":"LX Huang","year":"2022","unstructured":"Huang LX, Wang ZL, Jin R, Chen HS, Feng B. Incomplete response to ursodeoxycholic acid in primary biliary cholangitis: criteria, epidemiology, and possible mechanisms. Expert Rev Gastroenterol Hepatol. 2022;16(11\u201312):1065\u201378.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"4","key":"5040_CR7","doi-asserted-by":"publisher","first-page":"100662","DOI":"10.1016\/j.jhepr.2022.100662","volume":"5","author":"Y Yamashita","year":"2023","unstructured":"Yamashita Y, Umemura T, Kimura T, Joshita S, Hirohara J, Nakano T, et al. Prognostic utility of albumin-bilirubin grade in Japanese patients with primary biliary cholangitis. JHEP Rep. 2023;5(4):100662.","journal-title":"JHEP Rep"},{"issue":"1","key":"5040_CR8","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jceh.2020.09.003","volume":"11","author":"P Puri","year":"2021","unstructured":"Puri P, Dhiman RK, Taneja S, Tandon P, Merli M, Anand AC, et al. Nutrition in Chronic Liver Disease: Consensus Statement of the Indian National Association for Study of the Liver. J Clin Exp Hepatol. 2021;11(1):97\u2013143.","journal-title":"J Clin Exp Hepatol"},{"issue":"Suppl 1","key":"5040_CR9","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s40261-022-01141-x","volume":"42","author":"R de la Aller","year":"2022","unstructured":"de la Aller R. Nutrition and Chronic Liver Disease. Clin Drug Investig. 2022;42(Suppl 1):55\u201361.","journal-title":"Clin Drug Investig"},{"key":"5040_CR10","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.clnesp.2023.12.148","volume":"59","author":"CK Yang","year":"2024","unstructured":"Yang CK, Huang KT, Qin W, Wu QY, Huang XL, Peng K, et al. Prognostic value of geriatric nutritional risk index and prognostic nutritional index in hepatocellular carcinoma. Clin Nutr ESPEN. 2024;59:355\u201364.","journal-title":"Clin Nutr ESPEN"},{"key":"5040_CR11","doi-asserted-by":"crossref","unstructured":"Matsui M, Asai A, Ushiro K, Onishi S, Nishikawa T, Ohama H, et al. Prognostic Nutritional Index Correlates with Liver Function and Prognosis in Chronic Liver Disease Patients. Diagnostics (Basel). 2023;14(1):49.","DOI":"10.3390\/diagnostics14010049"},{"key":"5040_CR12","doi-asserted-by":"publisher","first-page":"1092059","DOI":"10.3389\/fnut.2022.1092059","volume":"9","author":"Y Xie","year":"2022","unstructured":"Xie Y, He C, Wang W. Prognostic nutritional index: A potential biomarker for predicting the prognosis of decompensated liver cirrhosis. Front Nutr. 2022;9:1092059.","journal-title":"Front Nutr"},{"issue":"1","key":"5040_CR13","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.asjsur.2021.04.043","volume":"45","author":"T Ryu","year":"2022","unstructured":"Ryu T, Takami Y, Wada Y, Sasaki S, Saitsu H. Predictive impact of the prognostic nutritional index in early-staged hepatocellular carcinoma after operative microwave ablation. Asian J Surg. 2022;45(1):202\u20137.","journal-title":"Asian J Surg"},{"key":"5040_CR14","doi-asserted-by":"publisher","first-page":"649","DOI":"10.2147\/JHC.S366107","volume":"9","author":"A Kornberg","year":"2022","unstructured":"Kornberg A, Kaschny L, Kornberg J, Friess H. Preoperative Prognostic Nutritional Index May Be a Strong Predictor of Hepatocellular Carcinoma Recurrence Following Liver Transplantation. J Hepatocell Carcinoma. 2022;9:649\u201360.","journal-title":"J Hepatocell Carcinoma"},{"issue":"5","key":"5040_CR15","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1016\/j.jhep.2022.06.014","volume":"77","author":"B Huang","year":"2022","unstructured":"Huang B, Lyu Z, Qian Q, Chen Y, Zhang J, Li B, et al. NUDT1 promotes the accumulation and longevity of CD103(+) T(RM) cells in primary biliary cholangitis. J Hepatol. 2022;77(5):1311\u201324.","journal-title":"J Hepatol"},{"issue":"3","key":"5040_CR16","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s00281-009-0167-2","volume":"31","author":"AT Borchers","year":"2009","unstructured":"Borchers AT, Shimoda S, Bowlus C, Keen CL, Gershwin ME. Lymphocyte recruitment and homing to the liver in primary biliary cirrhosis and primary sclerosing cholangitis. Semin Immunopathol. 2009;31(3):309\u201322.","journal-title":"Semin Immunopathol"},{"issue":"7","key":"5040_CR17","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1111\/j.1440-1746.2012.07118.x","volume":"27","author":"M Li","year":"2012","unstructured":"Li M, Zheng H, Li T, Gao P, Zhang XL, Liu DW. Cytotoxic T-lymphocyte associated antigen-4 gene polymorphisms and primary biliary cirrhosis: a systematic review. J Gastroenterol Hepatol. 2012;27(7):1159\u201366.","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"5040_CR18","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.jhep.2017.03.022","volume":"67","author":"European Association for the Study of the Liver","year":"2017","unstructured":"European Association for the Study of the Liver. Electronic address eee, European Association for the Study of the L. EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis. J Hepatol. 2017;67(1):145\u201372.","journal-title":"J Hepatol"},{"key":"5040_CR19","doi-asserted-by":"crossref","unstructured":"Yang Y, He X, Rojas M, Leung PSC, Gao L. Mechanism-based target therapy in primary biliary cholangitis: opportunities before liver cirrhosis? Front Immunol. 2023;14:1184252.","DOI":"10.3389\/fimmu.2023.1184252"},{"issue":"11","key":"5040_CR20","doi-asserted-by":"publisher","first-page":"e23501","DOI":"10.1002\/jcla.23501","volume":"34","author":"S Tian","year":"2020","unstructured":"Tian S, Liu Y, Sun K, Zhou X, Ma S, Zhang M, et al. A nomogram based on pretreatment clinical parameters for the prediction of inadequate biochemical response in primary biliary cholangitis. J Clin Lab Anal. 2020;34(11):e23501.","journal-title":"J Clin Lab Anal"},{"issue":"3","key":"5040_CR21","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1111\/jgh.13534","volume":"32","author":"L Tang","year":"2017","unstructured":"Tang L, Zhong R, He X, Wang W, Liu J, Zhu Y, et al. Evidence for the association between IgG-antimitochondrial antibody and biochemical response to ursodeoxycholic acid treatment in primary biliary cholangitis. J Gastroenterol Hepatol. 2017;32(3):659\u201366.","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"5040_CR22","doi-asserted-by":"publisher","first-page":"100546","DOI":"10.1016\/j.aohep.2021.100546","volume":"27","author":"GGL Can\u00e7ado","year":"2022","unstructured":"Can\u00e7ado GGL, Braga MH, Ferraz MLG, Villela-Nogueira CA, Terrabuio DRB, Can\u00e7ado ELR, et al. Clinical features and treatment outcomes of primary biliary cholangitis in a highly admixed population. Ann Hepatol. 2022;27(1):100546.","journal-title":"Ann Hepatol"},{"issue":"3","key":"5040_CR23","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1111\/liv.15141","volume":"42","author":"A Gerussi","year":"2022","unstructured":"Gerussi A, Verda D, Bernasconi DP, Carbone M, Komori A, Abe M, et al. Machine learning in primary biliary cholangitis: A novel approach for risk stratification. Liver Int. 2022;42(3):615\u201327.","journal-title":"Liver Int"},{"issue":"9","key":"5040_CR24","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/S2468-1253(18)30163-8","volume":"3","author":"M Carbone","year":"2018","unstructured":"Carbone M, Nardi A, Flack S, Carpino G, Varvaropoulou N, Gavrila C, et al. Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score. Lancet Gastroenterol Hepatol. 2018;3(9):626\u201334.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"3","key":"5040_CR25","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1002\/hep.28017","volume":"63","author":"M Carbone","year":"2016","unstructured":"Carbone M, Sharp SJ, Flack S, Paximadas D, Spiess K, Adgey C, et al. The UK-PBC risk scores: Derivation and validation of a scoring system for long-term prediction of end-stage liver disease in primary biliary cholangitis. Hepatology. 2016;63(3):930\u201350.","journal-title":"Hepatology"},{"key":"5040_CR26","doi-asserted-by":"crossref","unstructured":"Jamiol-Milc D, Gudan A, Kazmierczak-Siedlecka K, Holowko-Ziolek J, Maciejewska-Markiewicz D, Janda-Milczarek K, et al. Nutritional support for liver diseases. Nutrients. 2023;15(16):3640.","DOI":"10.3390\/nu15163640"},{"issue":"1","key":"5040_CR27","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.jhep.2018.06.024","volume":"70","author":"European Association for the Study of the Liver","year":"2019","unstructured":"European Association for the Study of the Liver. Electronic address eee, European Association for the Study of the L. EASL Clinical Practice Guidelines on nutrition in chronic liver disease. J Hepatol. 2019;70(1):172\u201393.","journal-title":"J Hepatol"},{"issue":"6","key":"5040_CR28","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1042\/CS20181123","volume":"133","author":"WT Ma","year":"2019","unstructured":"Ma WT, Chen DK. Immunological abnormalities in patients with primary biliary cholangitis. Clin Sci (Lond). 2019;133(6):741\u201360.","journal-title":"Clin Sci (Lond)"},{"issue":"7","key":"5040_CR29","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1007\/s10620-021-07165-1","volume":"67","author":"S Zhang","year":"2022","unstructured":"Zhang S, Tao X, Wang L, Chen H, Zhao L, Sun J, et al. Downregulation of Programmed Death-1 Pathway Promoting CD8\u2009+\u2009T Cell Cytotoxicity in Primary Biliary Cholangitis. Dig Dis Sci. 2022;67(7):2981\u201393.","journal-title":"Dig Dis Sci"},{"issue":"3","key":"5040_CR30","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.jaut.2010.06.004","volume":"35","author":"F Bernuzzi","year":"2010","unstructured":"Bernuzzi F, Fenoglio D, Battaglia F, Fravega M, Gershwin ME, Indiveri F, et al. Phenotypical and functional alterations of CD8 regulatory T cells in primary biliary cirrhosis. J Autoimmun. 2010;35(3):176\u201380.","journal-title":"J Autoimmun"},{"issue":"1","key":"5040_CR31","doi-asserted-by":"publisher","first-page":"12584","DOI":"10.1038\/s41598-020-69358-4","volume":"10","author":"JS Jang","year":"2020","unstructured":"Jang JS, Juran BD, Cunningham KY, Gupta VK, Son YM, Yang JD, et al. Single-cell mass cytometry on peripheral blood identifies immune cell subsets associated with primary biliary cholangitis. Sci Rep. 2020;10(1):12584.","journal-title":"Sci Rep"},{"issue":"2","key":"5040_CR32","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1002\/hep.22042","volume":"47","author":"ME Gershwin","year":"2008","unstructured":"Gershwin ME, Mackay IR. The causes of primary biliary cirrhosis: Convenient and inconvenient truths. Hepatology. 2008;47(2):737\u201345.","journal-title":"Hepatology"},{"issue":"1","key":"5040_CR33","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1055\/s-0039-1697617","volume":"40","author":"A Lleo","year":"2020","unstructured":"Lleo A, Leung PSC, Hirschfield GM, Gershwin EM. The Pathogenesis of Primary Biliary Cholangitis: A Comprehensive Review. Semin Liver Dis. 2020;40(1):34\u201348.","journal-title":"Semin Liver Dis"},{"issue":"1","key":"5040_CR34","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.cld.2023.06.006","volume":"28","author":"I Houri","year":"2024","unstructured":"Houri I, Hirschfield GM. Primary Biliary Cholangitis. Clin Liver Dis. 2024;28(1):79\u201392.","journal-title":"Clin Liver Dis"},{"issue":"2","key":"5040_CR35","first-page":"196","volume":"30","author":"S Chen","year":"2022","unstructured":"Chen S, Duan WJ, You H, Ma X, Jia JD. [Recommendations of APASL clinical practice guidance: the diagnosis and management of patients with primary biliary cholangitis]. Zhonghua gan zang bing za zhi\u2009=\u2009Zhonghua ganzangbing zazhi\u2009=\u2009Chinese. J Hepatol. 2022;30(2):196\u20138.","journal-title":"J Hepatol"},{"issue":"10","key":"5040_CR36","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1038\/ajg.2010.216","volume":"105","author":"T Kumagi","year":"2010","unstructured":"Kumagi T, Guindi M, Fischer SE, Arenovich T, Abdalian R, Coltescu C, et al. Baseline ductopenia and treatment response predict long-term histological progression in primary biliary cirrhosis. Am J Gastroenterol. 2010;105(10):2186\u201394.","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"5040_CR37","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1016\/j.jhep.2011.02.031","volume":"55","author":"C Corpechot","year":"2011","unstructured":"Corpechot C, Chazouill\u00e8res O, Poupon R. Early primary biliary cirrhosis: biochemical response to treatment and prediction of long-term outcome. J Hepatol. 2011;55(6):1361\u20137.","journal-title":"J Hepatol"},{"key":"5040_CR38","doi-asserted-by":"publisher","first-page":"1219929","DOI":"10.3389\/fimmu.2023.1219929","volume":"14","author":"L Zhang","year":"2023","unstructured":"Zhang L, Ma W, Qiu Z, Kuang T, Wang K, Hu B, et al. Prognostic nutritional index as a prognostic biomarker for gastrointestinal cancer patients treated with immune checkpoint inhibitors. Front Immunol. 2023;14:1219929.","journal-title":"Front Immunol"},{"key":"5040_CR39","doi-asserted-by":"crossref","unstructured":"Marenco-Flores A, Rojas Amaris N, Kahan T, Sierra L, Barba Bernal R, Medina-Morales E, et al. The external validation of GLOBE and UK-PBC risk scores for predicting ursodeoxycholic acid treatment response in a large U.S. Cohort of Primary Biliary Cholangitis Patients. J Clin Med. 2024;13(15):4497.","DOI":"10.3390\/jcm13154497"},{"issue":"4","key":"5040_CR40","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.jhep.2024.05.010","volume":"81","author":"AJ Montano-Loza","year":"2024","unstructured":"Montano-Loza AJ, Lytvyak E, Hirschfield G, Hansen BE, Ebadi M, Berney T, et al. Prognostic scores for ursodeoxycholic acid-treated patients predict graft loss and mortality in recurrent primary biliary cholangitis after liver transplantation. J Hepatol. 2024;81(4):679\u201389.","journal-title":"J Hepatol"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-026-05040-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-05040-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-05040-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T01:27:25Z","timestamp":1788744445000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12876-026-05040-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,24]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5040"],"URL":"https:\/\/doi.org\/10.1186\/s12876-026-05040-9","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,24]]},"assertion":[{"value":"29 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The present study protocol was approved by the Ethics Committee of the Second Affiliated Hospital of Kunming Medical University. The requirement for informed consent was waived by Ethics Committee of the Second Affiliated Hospital of Kunming Medical University (YJ-2023-96) due to retrospective nature of study.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"545"}}